Skip to content

The Effect of Valerian on Insomnia in Menopausal Women

The Effect of Valerian on Insomnia in Menopausal Women: Randomized Placebo-controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05185219
Enrollment
100
Registered
2022-01-11
Start date
2021-12-14
Completion date
2025-01-20
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Menopausal Women

Keywords

menopause, insomnia, valerian

Brief summary

Menopausal women often complain that it is difficult to fall asleep and easy to wake up at night and early in the morning and it is in the middle of night difficult to fall asleep again. If the above symptoms persist for at least three months and occur at least three times a week, plus the impact on daytime work and rest, and meet the International Classification of Sleep Disorders (ICSD-3) )'S s Insomnia diagnostic criteria. According to statistics, 30% to 60% of women face sleep disorders during menopause.

Detailed description

The investigators expect to receive outpatient admissions in the hospital attached to China Medical University. Menopausal women aged 45-60 years old who have been diagnosed with insomnia who meet criteria of International Classification of Sleep Disorders (ICSD-3) will be randomly assigned for clinical trials. Patients will take two Valerian capsules (1000mg/day) per day for four weeks. Pittsburgh Sleep Index (PSQI) will be used to evaluate subjective sleep quality. TCM patterns will be evaluated by three physicians of TCM gynecology independently before and after taking Valeriana. The data will conduct a biological analysis to compare the difference in sleep quality between the trial group and the control group.

Interventions

A natural plant

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. 45〜60 years old, and is menopaused for at least 1 year。 2. meet the criteria of ICSD-3 for insomnia 3. PSQI \> 5

Exclusion criteria

1. psychiatry disease 2. Heart, brain, liver diseases 3. Insomnia is caused by diseases. 4. Steroid used within 6 months 5. pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Sleep quallity30 daysSleep quality will be evaluated by Pittsburgh Sleep Index (PSQI). The sum of the scores on PSQI ranges from 0 to 21, and higher scores mean a worse outcome.

Secondary

MeasureTime frameDescription
Traditional Chinese medicine (TCM) constitution30 daysTCM constitution will be measured by three TCM doctor and TCM questionnaire

Countries

Taiwan

Contacts

Primary ContactShan-Yu Su
shanyusu@gmail.com0975682032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026